Form 4 Tracker
CORCEPT THERAPEUTICS INC
CORT

84 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 15, 2026Oct 16 10:24 PMJames N WilsonDirector
Sale
10,000$114.81$1.1M1,054,543(I)

View →

Oct 2, 2026Oct 5 11:58 PMRoberto Wandenkolk VieiraPresident, Oncology
Sale
8,333$116.10$967.4K3,946(D)

View →

Oct 2, 2026Oct 5 11:54 PMJoseph Douglas LyonChief Accounting & Technology Officer
Sale
9,190$116.13$1.1M5,683(D)

View →

Oct 1, 2026Oct 5 11:54 PMJoseph Douglas LyonChief Accounting & Technology Officer
Sale
810$115.40$93.5K5,683(D)

View →

Oct 2, 2026Oct 5 11:49 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Sale
24,587$116.28$2.9M9,938(D)

View →

Oct 1, 2026Oct 5 11:49 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Sale
413$115.54$47.7K9,938(D)

View →

Oct 1, 2026Oct 1 3:09 PMLyon Joseph Douglas
Proposed Sale
10,000$115.23$1.2M—

View →

Sep 16, 2026Sep 18 11:53 PMRoberto Wandenkolk VieiraPresident, Oncology
Sale
296$100.82$29.8K3,946(D)

View →

Sep 14, 2026Sep 16 8:30 PMJoseph Douglas LyonChief Accounting & Technology Officer
Sale
10,000$113.49$1.1M5,683(D)

View →

Sep 15, 2026Sep 16 8:30 PMJames N WilsonDirector
Sale
10,000$110.69$1.1M1,064,543(I)

View →

Sep 15, 2026Sep 15 2:23 PMWILSON JAMES N
Proposed Sale
30,000$111.48$3.3M—

View →

Sep 14, 2026Sep 14 5:58 PMLyon Joseph Douglas
Proposed Sale
10,000$113.44$1.1M—

View →

Sep 1, 2026Sep 4 1:16 AMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Sale
25,000$114.43$2.9M9,755(D)

View →

Sep 2, 2026Sep 4 1:02 AMRoberto Wandenkolk VieiraPresident, Oncology
Sale
58,333$110.76$6.5M4,242(D)

View →

Sep 2, 2026Sep 2 8:08 PMVieira Roberto Wandenkolk
Proposed Sale
75,295$110.76$8.3M—

View →

Aug 26, 2026Aug 28 8:30 PMKimberly ParkDirector
Sale
26,685$122.55$3.3M0(D)

View →

Aug 25, 2026Aug 27 8:30 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Sale
30,955$125.58$3.9M9,755(D)

View →

Aug 26, 2026Aug 26 8:14 PMKIMBERLY PARK
Proposed Sale
26,685$122.55$3.3M—

View →

Aug 25, 2026Aug 25 9:24 PMMaduck Sean
Proposed Sale
175,000$125.58$22.0M—

View →

Aug 18, 2026Aug 20 8:30 PMDavid L MahoneyDirector
Sale
103,606$118.25$12.3M1,133,539(I)

View →

Page 1 of 8

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 1, 2026Jul 6 8:44 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
25,000$8.27116,986(D)

View →

Jun 15, 2026Jun 17 8:30 PMAtabak MokariChief Financial Officer
Option Exercise
40,000$19.2620,000(D)

View →

Jun 2, 2026Jun 4 8:49 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65150,000(D)

View →

Jun 1, 2026Jun 3 11:20 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
25,000$8.27141,986(D)

View →

Jun 1, 2026Jun 3 11:20 PMAtabak MokariChief Financial Officer
Option Exercise
40,000$19.2660,000(D)

View →

May 27, 2026May 29 10:03 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
75,000$8.27166,986(D)

View →

May 21, 2026May 26 9:40 PMBAKER G LEONARD JRDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:39 PMGregg H AltonDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:36 PMJames N WilsonDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:35 PMDaniel N Swisher JRDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:33 PMJoshua M. MurrayDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:31 PMDavid L MahoneyDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:28 PMKimberly ParkDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 5, 2026May 7 8:30 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65170,000(D)

View →

Apr 7, 2026Apr 8 11:34 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65190,000(D)

View →

Mar 20, 2026Mar 24 8:54 PMWilliam GuyerChief Development Officer
Option Exercise
11,767$21.65210,000(D)

View →

Mar 13, 2026Mar 17 11:52 PMDavid L MahoneyDirector
Option Exercise
30,000$5.860(D)

View →

Mar 4, 2026Mar 6 9:30 PMWilliam GuyerChief Development Officer
Option Exercise
8,233$21.65221,767(D)

View →

Feb 27, 2026Mar 3 11:19 PMJoseph Douglas LyonChief Accounting & Technology Officer
Grant/Award
140,000$35.70140,000(D)

View →

Feb 27, 2026Mar 3 11:17 PMBELANOFF JOSEPH KDirector, Chief Executive Officer
Grant/Award
460,000$35.70460,000(D)

View →